Standard BioTools purchases the LSAXT system from Carterra, no terms

Standard BioTools announced that it has purchased the LSAXT system from Carterra, a provider of high-throughput large and small molecule screening and characterization solutions. This instrument will enable Standard BioTools to further validate its SomaScan Platform by measuring the kinetic properties of SOMAmer Reagents and deliver precise information about protein binding and biomarker characterization to customers. The LSAXT was chosen for its ability to deliver more data in a fraction of the time of other instruments. Standard BioTools research teams will use this capability to identify precise binding sites on proteins for their SOMAmer Reagents. These teams are also interested in identifying proteins that bind to more than one SOMAmer Reagent, creating avenues for biomarker discovery and the development of diagnostic tests. “We are focused on giving our customers complete confidence in the precision and specificity of our SomaScan Platform,” said Michael Egholm, President and Chief Executive Officer of Standard BioTools. “The Carterra LSAXT will provide a deeper understanding of protein interactions that will allow us to continue to deliver that confidence and continue to improve our offerings.”